www.oltca.com   LONG TERM CARE TODAY
19
demonstrated its ability to clearly document wound 
progression over time, creating a clear and comprehensive 
record for both clinicians and administrators. 
Saving time was another outcome. By automatically 
measuring wounds and tracking changes over time, as well 
as consolidating assessments, treatment recommendations 
and images into a single platform, Skinopathy Wounds 
demonstrated its ability to eliminate manual tasks that 
traditionally consume nurses' time. “I found it helpful that 
the AI makes recommendations while still integrating the 
clinician’s own skills and knowledge,” Muhammed says.
"Seeing clinicians realize they can spend more time doing 
what they want to do, helping patients, has been the 
biggest eye-opener for me," Loo adds.
In addition to expediting the assessment process – “a big 
deal for the nurses working on the floor,” Muhammed 
says – the team also found Skinopathy Wounds effective 
in identifying tissue composition and recommending 
appropriate dressings based on products already available 
in the home. It also allowed nurses to refer cases directly 
to a physician or wound care specialist from within the 
app. At a broader level, the evaluation demonstrated  
how AI technologies could be especially valuable in 
providing evidence-based guidance to less experienced 
nurses when specialized wound care expertise isn't 
immediately available.
Perhaps the most significant outcome of the evaluation 
was improved consistency, Killing says. By accounting for 
factors such as skin tone, lighting conditions, and wound 
composition, Skinopathy Wounds helped clinicians make 
more consistent assessments while recommending 
appropriate dressings. That consistency has important 
clinical implications. At peopleCare, for example, Killing 
explains that wounds that deteriorate over two consecutive 
assessments are referred to a specialist. Inconsistent 
assessments can delay those referrals.
The above observations were reflected in the evaluation 
findings. Documentation completion reached 98.6%, 
while the average wound assessment took just 6.5 
minutes, compared with the typical 10 to 15 minutes. 
During the evaluation, one in four difficult-to-heal wounds 
healed, while more than one-third were identified early 
for enhanced care. Together, the findings point to the 
potential for AI to support more timely, consistent wound 
care in long-term care settings.
Refining the technology 
One of peopleCare's goals for the initiative was to help 
Skinopathy better understand the realities of wound care 
in long-term care, so that the company could create a 
platform built around the needs of Ontario's long-term 
care nurses, rather than one adapted to them after the fact.
Dr. Rakesh Joshi, a Lead Scientist at Skinopathy, worked 
across the two organizations to do just that. "We learned 
that technology is only going to be adopted if it fits into 
nurses' day-to-day workflow," he says.
That lesson has shaped how Skinopathy is now deploying 
the platform. While the core AI remains the same, Joshi 
says the company is customizing the technology to reflect 
each home's existing workflows, dressing supplies, policies 
and care protocols. "The core technology is going to be 
the same, but we're going to tailor to each specific long-
term care home. We realized that if you don't do that, 
nurses will not get the full benefit of your system,” he says.
Building on the experience  
With the peopleCare evaluation complete, Skinopathy 
is currently focused on expanding access, continuing 
research and helping more long-term care residents in 
Ontario. For co-founder Dr. Allan Wu, OLTCA’s Together 
We Care conference marked a turning point in that regard. 
"Together We Care was a phenomenal opportunity for us 
to actually meet the community," he says, noting those 
connections are now helping launch the company's 
commercialization efforts. At the same time, the company 
is partnering with the National Research Council on a two-
year research initiative to further enhance the technology 
and expand its use across the continuum of care, from 
home care and outpatient clinics to long-term care.
While Skinopathy looks ahead to the next phase of its own 
work, peopleCare is reflecting on what was learned.
"Not every evaluation project leads directly to 
implementation, and that's OK," says Killing. "The research 
matters. We set out to answer important questions about 
how AI could support wound care in long-term care, 
and we answered nearly all of them. Along the way, we 
strengthened our own wound care program and generated 
evidence that can help inform future innovation across the 
sector. Those outcomes continue to have value, regardless 
of where the technology goes next."  LTCT
WOUND CARE

View this content as a flipbook by clicking here.